文献速递儿科与产科急症重症综合管理与镇静镇痛

认知状态量表:在临床转诊儿科重症监护样本中的心理测量学特性初步研究

The Cognitive Status Scale: A Preliminary Investigation of Psychometric Properties in a Clinically Referred Pediatric Critical Care Sample.
PubMed 文献 · Neurocrit Care · 2025-05-16
一句话结论认知状态量表(CSS)在儿科重症监护后6-19岁临床转诊样本中显示良好的内部一致性(α=0.82)和评分者间信度(r=0.92),结构效度与效标关联效度初步支持其用于汇总认知评估。

本研究分两阶段:开发认知状态量表(CSS),并在110例6-19岁儿科重症监护后临床转诊青少年中回顾性试测其心理测量学特性。主成分分析支持CSS结构(解释总方差59%),内部一致性α=0.82,评分者间信度r=0.92。长期评估的CSS总分与急性恢复期简版认知表现指标(神经认知指数)显著相关(r=0.74)。已知临床组间CSS总分差异显著:功能状态量表(FSS)变化≥3分组为30.23,≤2分组为50.94(t=4.10,p≤0.001,d=0.91)。CSS总分与FSS总分(r=-0.44,p≤0.001)及执行功能行为评定量表第二版一般执行综合分(r=-0.29,p=0.010)呈预期方向的显著关联。作者认为CSS是汇总临床认知评估组合的可靠且有效的测量工具。

要点

  • CSS内部一致性良好(α=0.82),评分者间信度良好(r=0.92),可用于汇总临床实施的认知评估组合。
  • 长期评估CSS总分与急性恢复期神经认知指数显著相关(r=0.74),支持效标关联效度。
  • FSS变化≥3分组CSS总分30.23 vs FSS变化≤2分组50.94(t=4.10,p≤0.001,d=0.91),组间差异显著。
  • CSS总分与FSS总分呈负相关(r=-0.44,p≤0.001),与执行功能行为评定量表第二版一般执行综合分呈负相关(r=-0.29,p=0.010)。
  • 主成分分析支持CSS结构,解释总方差59%。

适用人群与场景

  • 6-19岁儿科重症监护后临床转诊青少年(N=110),用于研究目的汇总临床生成和表现为基础的神经心理结局。

研究设计与关键结果

  • 研究类型:量表开发与回顾性试测;样本量N=110;人群:6-19岁儿科重症监护后临床转诊青少年。
  • 主成分分析支持CSS结构,解释总方差59%。
  • 内部一致性α=0.82,评分者间信度r=0.92。
  • 效标关联效度:长期评估CSS总分与急性恢复期神经认知指数显著相关(r=0.74)。
  • 区分效度:FSS变化≥3分组CSS总分30.23 vs FSS变化≤2分组50.94(t=4.10,p≤0.001,d=0.91)。
  • CSS临床指标间差异显著(F3,106=8.4495,p<0.001,η2=0.194)。
  • CSS总分与FSS总分呈负相关(r=-0.44,p≤0.001),与执行功能行为评定量表第二版一般执行综合分呈负相关(r=-0.29,p=0.010)。

证据类型、等级与局限

  • 证据类型:量表开发与回顾性试点研究(初步调查)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为CSS是汇总临床实施的认知评估组合的可靠且有效的测量工具。
  • 作者认为易于生成的表现为基础认知指标对推进儿科重症监护后认知结局的科学至关重要。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Cognitive morbidities persist after pediatric critical care. However, a significant gap exists related to measuring cognitive outcomes in this patient population due to heterogeneity in presentations and objective measures. This study's purpose was to develop a psychometrically sound coding system to summarize clinically generated and performance-based neuropsychological outcomes to be used for research.

METHODS: The work was conducted in two stages: (1) Cognitive Status Scale (CSS) development and (2) a retrospective pilot test in a clinically referred sample of post-critical-care youth aged 6-19 years (N = 110) to explore preliminary psychometric properties of the CSS.

RESULTS: Principal components analysis supported the CSS structure (capturing 59% of the total explained variance). Internal consistency (α = 0.82) and interrater reliability (r = 0.92) were good. Within the full sample, criterion-related validity was demonstrated as the CSS total composite score from long-term evaluation and was significantly correlated with abbreviated performance-based cognitive outcomes from the acute recovery phase (Neurocognitive Index, r = 0.74). Divergent validity was shown via significant differences on the CSS total composite score between known clinical groups (≥ 3 Functional Status Scale [FFS] change = 30.23 vs. ≤ 2 FFS change = 50.94, t = 4.10, p ≤ 0.001, d = 0.91) and across CSS clinical indicators (F3,106 = 8.4495, p = < 0.001, η2 = 0.194). Bivariate correlations showed a significant association in the expected direction between the CSS total composite score and the Functional Status Scale total score (r = - 0.44, p ≤ 0.001), as well as a significant association in the expected direction between the CSS total composite score and the Behavior Rating Inventory of Executive Function, Second Edition General Executive Composite (r = - 0.29, p = 0.010).

CONCLUSIONS: Primary evidence shows the CSS to be a reliable and valid measure for summarizing a clinically administered battery of cognitive assessments. Easy-to-generate metrics of performance-based cognition are essential to progress the state of the science germane to cognitive outcomes post pediatric critical care.

来源:Neurocrit Care,查看原文。版权归原作者所有。

参考来源

  1. Hall TA, Duvall SW, Demers L, et al. The Cognitive Status Scale: A Preliminary Investigation of Psychometric Properties in a Clinically Referred Pediatric Critical Care Sample. Neurocrit Care. 2025. PMID: 40375047. doi:10.1007/s12028-025-02281-6

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。